(1) The board shall establish a prescription drug registry advisory group, to provide information and recommendations about the development, operation, enhancement, and clinical application of the prescription drug registry.
Authorizing statute(s): 37-7-1510, 37-7-1512, MCA
Implementing statute(s): 37-7-1510, MCA
History: NEW, 2012 MAR p. 506, Eff. 3/9/12; AMD, 2024 MAR p. 2219, Eff. 9/21/24.